AWARDDELIVERY ORDEROther than small business
Delivery order 75N91025F00001THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM
Overview
Award facts
- Net obligations
- $1.32M
- $1,324,125of $1.32M potential value
- Outlays (paid to date)
- $115.26K
- $115.26K paid of $1.32M obligated$115,263
- Period of performance
- Sep 25, 2025 to Mar 24, 2028
- Ends in 16 months
- Modifications
- 1
- Latest action Aug 10, 2026
- Contract type
- Delivery order
- PIID 75N91025F00001
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC)
Dates and value
- Award date
- Signed on Sep 22, 2025
- Current value
- $1,324,125Base and exercised options
- Potential value (if all options are exercised)
- $1,324,125
- Parent contract vehicle
- 75N91024D00004 (IDC, multiple award) — 2 orders recorded under it
Obligations by fiscal year of action
- FY2026: $632,547
- FY2025: $691,578
Total across 2 fiscal years: $1,324,125
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 10, 2026. View on USAspending · Recipient on SAM.gov
Recipient
NameTHE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM
LocationHOUSTON, TX
UEIS3GMKS8ELA16
CAGE code0KD38
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity
Parent companyTHE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Business types and certifications
Educational institutionU.S. government entity
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH NCI
- Funded from
- National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Houston, Harris County, Texas 77030-1500
- Congressional district (place of performance)
- TX-09As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- No set-aside used
- Contract pricing
- Cost sharingT
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- TORFP 2025-E-01(as reported)
- Solicitation date
- Jul 15, 2025
Contract details
- Subcontracting plan
- Individual subcontract planF
- Major program
- Low-dose erlotinib and mesalamine for prevention of colitis-associated colorectal cancer (CAC)
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 22, 2025Base obligation at award: $691,578
- Latest action
- Aug 10, 2026 — Option exercisedModification P00001; obligation change +$632,547
- Latest substantive action
- Aug 10, 2026 — Option exercisedModification P00001; obligation change +$632,547
- Actions by type
- Base award1
- Option exercised1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $632,547
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Bio-basedE
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- Other U.S. entity (e.g. government)B
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- National Institutes Of Health7529
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N910
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N910
- Treasury accounts
- 075-2025/2025-0849-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression